700-Patient study aims to unlock early clues to Parkinson's and MSA

NCT ID NCT07353463

Recruiting now Knowledge-focused Sponsor: Ruijin Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is following 700 people with Parkinson's disease or multiple system atrophy in Shanghai. Researchers will collect medical history, brain scans, blood samples, and other data every six months. The goal is to find early signs of these diseases and better predict how they will progress, which could lead to earlier diagnosis and personalized treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors diagnose Parkinson's and MSA earlier and more accurately, and guide development of new treatments.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test any new drug or therapy, so benefits for patients are long-term and uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple system atrophy Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SYSTEM ATROPHY PARKINSON'S DISEASE (PD)

Contacts and locations

Locations

Department of neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
RECRUITING

Shanghai, 200025, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.